Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$390M |
| 2 |
Alibaba
BABA
|
+$330M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$253M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$325M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$303M |
| 3 |
PX
Praxair Inc
PX
|
+$213M |
| 4 |
COL
Rockwell Collins
COL
|
+$103M |
| 5 |
ANDV
Andeavor
ANDV
|
+$96.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.36% |
| 2 | Financials | 15.21% |
| 3 | Healthcare | 13.81% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFE
1976
DELISTED
Safeguard Scientifics, Inc.
SFE
| $796K | ﹤0.01% |
92,286
+4,603
| +5% | +$40.2K |
|
1977
HCI Group
HCI
$2.28B
| $794K | ﹤0.01% |
15,637
+43
| +0.3% | +$2.1K |
|
|
FOLD
1978
DELISTED
Amicus Therapeutics
FOLD
| $793K | ﹤0.01% |
82,835
+16,234
| +24% | +$178K |
|
1979
LeMaitre Vascular
LMAT
$1.81B
| $792K | ﹤0.01% |
33,541
-244
| -0.7% | -$6.66K |
|
1980
Ichor Holdings
ICHR
$2.46B
| $790K | ﹤0.01% |
48,808
-3,349
| -6% | -$57.9K |
|
|
PENG
1981
Penguin Solutions Inc
PENG
$2.86B
| $788K | ﹤0.01% |
53,110
+50,202
| +1,726% | +$759K |
|
1982
ANI Pharmaceuticals
ANIP
$1.8B
| $784K | ﹤0.01% |
17,565
-147
| -0.8% | -$7.7K |
|
|
NXTM
1983
DELISTED
NxStage Medical Inc.
NXTM
| $784K | ﹤0.01% |
27,377
+5,449
| +25% | +$155K |
|
|
CSFL
1984
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $781K | ﹤0.01% |
37,138
+2,378
| +7% | +$57.6K |
|
1985
Zumiez
ZUMZ
$330M
| $777K | ﹤0.01% |
40,656
+841
| +2% | +$17.8K |
|
1986
TriNet
TNET
$3.14B
| $776K | ﹤0.01% |
18,501
+3,610
| +24% | +$166K |
|
1987
Central Garden & Pet Co
CENT
$2.76B
| $773K | ﹤0.01% |
28,139
+594
| +2% | +$15.6K |
|
|
ARNA
1988
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $773K | ﹤0.01% |
19,852
+1,218
| +7% | +$47.8K |
|
1989
Haverty Furniture Companies
HVT
$450M
| $756K | ﹤0.01% |
40,390
-27
| -0.1% | -$555 |
|
1990
American Coastal Insurance
ACIC
$531M
| $755K | ﹤0.01% |
45,488
+86
| +0.2% | +$1.64K |
|
|
LDL
1991
DELISTED
Lydall, Inc.
LDL
| $755K | ﹤0.01% |
37,014
-40
| -0.1% | -$1.09K |
|
1992
Park Aerospace
PKE
$822M
| $751K | ﹤0.01% |
41,472
+707
| +2% | +$12.8K |
|
|
NGHC
1993
DELISTED
National General Holdings Corp
NGHC
| $751K | ﹤0.01% |
31,007
+7,058
| +29% | +$180K |
|
1994
Community Health Systems
CYH
$416M
| $750K | ﹤0.01% |
264,697
-2,109
| -0.8% | -$7.24K |
|
|
WLH
1995
DELISTED
WILLIAM LYON HOMES
WLH
| $750K | ﹤0.01% |
69,902
-694
| -1% | -$8.87K |
|
|
WBT
1996
DELISTED
Welbilt, Inc.
WBT
| $749K | ﹤0.01% |
67,368
+3,162
| +5% | +$48.8K |
|
|
AKRX
1997
DELISTED
Akorn Inc
AKRX
| $747K | ﹤0.01% |
219,190
+128,099
| +141% | +$762K |
|
1998
Cushman & Wakefield Ltd
CWK
$3.29B
| $746K | ﹤0.01% |
51,545
-72,582
| -58% | -$1.21M |
|
1999
Copa Holdings
CPA
$6.15B
| $744K | ﹤0.01% |
9,455
| – | – |
|
|
PGNX
2000
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $744K | ﹤0.01% |
179,219
| – | – |
|
Similar funds
Legal & General Group's Q4 2018 Portfolio in Review
As of Q4 2018, Legal & General Group held 3,449 positions worth $129B, down 7.6% from $140B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Legal & General Group deployed $9.23B of net new capital in Q4 2018, opening 63 new positions and adding to 2,242 existing holdings. Its largest new stake was Linde: 2,465,565 shares worth $381M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dell, an estimated $53.7M trimmed.
- Legal & General Group's largest Q4 2018 buy was Linde: 2,465,565 shares worth $381M.
- Legal & General Group added most to Alibaba in Q4 2018, an estimated $330M increase.
- Legal & General Group's biggest Q4 2018 reduction was Dell, cutting an estimated $53.7M.
- Legal & General Group fully exited Aetna Inc in Q4 2018, selling an estimated $325M.
- Legal & General Group's ten largest holdings make up 16% of its $129B portfolio in Q4 2018.
- Legal & General Group opened 63 new positions and closed 67 in Q4 2018.
- Legal & General Group's portfolio value fell 7.6% quarter-over-quarter to $129B.
Based on Legal & General Group's 13F filing for Q4 2018, filed 15 Feb 2019.